25 clinical trials matched your search for Pancreatic Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Pancreatic Cancer The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) Fay Kastrinos, MD
Pancreatic Cancer Study of Multiple Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) Gulam Manji, MD, PhD
Pancreatic Cancer Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery Susan Bates, MD
Pancreatic Cancer Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma Gulam Manji, MD, PhD
Pancreatic Cancer Registry Study to Evaluate the Nanoknife System in Treating Stage 3 Pancreatic Adenocarcinoma Michael Kluger, MD, MPH
Pancreatic Cancer Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) Susan Bates, MD
Pancreatic Cancer Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer Susan Bates, MD
Pancreatic Cancer Study of Drug - SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) Gulam Manji, MD, PhD
Cancer Study of IDE196 in Patients with Solid Tumors Shaheer Khan, DO
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer David Horowitz, MD
Cancer Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer Benjamin Herzberg, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Shaheer Khan, DO
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of E-602 Alone or in Combination with Libtayo (Cemiplimab) in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE